Dr. Agarwal's Health Care Limited (BOM:544350)

India · Delayed Price · Currency is INR

472.90

-4.45 (-0.93%)

At close: Oct 28, 2026

Market Cap	150.63B -8.3%
Revenue (ttm)	22.07B +22.9%
Net Income	1.48B +46.1%
EPS	4.65 +41.8%
Shares Out	n/a
PE Ratio	101.73
Forward PE	71.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,811
Open	474.25
Previous Close	477.35
Day's Range	462.30 - 478.25
52-Week Range	402.10 - 567.30
Beta	n/a
Analysts	Strong Buy
Price Target	584.60 (+23.62%)
Earnings Date	Nov 5, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited engages in running, owning, and managing eye care hospitals, opticals, pharmacies, etc. and related services in India and internationally. It offers femto cataracts, lenticular procedure, retinal surgeries, anterior segment reconstruction, and corneal transplants, as well as refractive and other surgeries. The company also develops, designs, manufactures, imports, and exports healthcare devices, which include ophthalmic diagnostic devices, such as auto perimeter, optical biometers, and ophthalmoscopes. In addit... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2010

Employees 4,214

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544350

Full Company Profile

Financial Performance

In fiscal year 2026, Dr. Agarwal's Health Care's revenue was 20.80 billion, an increase of 21.57% compared to the previous year's 17.11 billion. Earnings were 1.33 billion, an increase of 59.59%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 544350 stock is "Strong Buy." The 12-month stock price target is ₹584.60, which is an increase of 23.62% from the latest price.

Price Target

₹584.60

(23.62% upside)

Analyst Consensus: Strong Buy

Stock Forecasts